fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations
- RxCUI
- 1918203
- RxNorm name
- fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations
- Display name
- fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations
- Full name
- fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fluticasone Propionate and Salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | Bryant Ranch Prepack | f3bce31d-93f9-4ca6-835e-b16e2d31b6c5 | 2025-08-21 | Warnings, Adverse reactions | 1918203 |
| Fluticasone Propionate and Salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | A-S Medication Solutions | 77269609-fb89-47c7-97cc-22e0183e91ae | 2025-04-02 | Warnings, Adverse reactions | 1918203 |
| Fluticasone Propionate and Salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | Teva Pharmaceuticals USA, Inc. | 43a27267-2f2b-410d-9c30-9cb95f35d9a1 | 2024-02-09 | Warnings, Adverse reactions | 1918203 |
| AirDuo RespiClick | FLUTICASONE PROPIONATE AND SALMETEROL | Teva Respiratory, LLC | 9c122b91-a11f-49ca-80bb-3eec5112db87 | 2024-02-06 | Warnings, Adverse reactions | 1918203 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f3bce31d-93f9-4ca6-835e-b16e2d31b6c5 | 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | SCD | 104 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250821 |
| f3bce31d-93f9-4ca6-835e-b16e2d31b6c5 | fluticasone propionate 232 MCG/ACTUAT / salmeterol xinafoate 14 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUATS | SY | 104 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250821 |
| f3bce31d-93f9-4ca6-835e-b16e2d31b6c5 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | PSN | 104 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250821 |
| 77269609-fb89-47c7-97cc-22e0183e91ae | 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | SCD | 25 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250402 |
| 77269609-fb89-47c7-97cc-22e0183e91ae | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | PSN | 25 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250402 |
| 77269609-fb89-47c7-97cc-22e0183e91ae | fluticasone propionate 232 MCG/ACTUAT / salmeterol xinafoate 14 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUATS | SY | 25 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250402 |
| 43a27267-2f2b-410d-9c30-9cb95f35d9a1 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | PSN | 18 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20240209 |
| 43a27267-2f2b-410d-9c30-9cb95f35d9a1 | 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | SCD | 18 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20240209 |
| 43a27267-2f2b-410d-9c30-9cb95f35d9a1 | fluticasone propionate 232 MCG/ACTUAT / salmeterol xinafoate 14 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUATS | SY | 18 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. Fluticasone Propionate and Salmeterol inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20240209 |
| 9c122b91-a11f-49ca-80bb-3eec5112db87 | fluticasone propionate 232 MCG/ACTUAT / salmeterol xinafoate 14 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUATS | SY | 16 | These highlights do not include all the information needed to use AIRDUO ® RESPICLICK ® safely and effectively. See full prescribing information for AIRDUO RESPICLICK. AIRDUO RESPICLICK (fluticasone propionate and salmeterol) inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20240206 |
| 9c122b91-a11f-49ca-80bb-3eec5112db87 | 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler | SCD | 16 | These highlights do not include all the information needed to use AIRDUO ® RESPICLICK ® safely and effectively. See full prescribing information for AIRDUO RESPICLICK. AIRDUO RESPICLICK (fluticasone propionate and salmeterol) inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20240206 |
| 9c122b91-a11f-49ca-80bb-3eec5112db87 | fluticasone propionate/salmeterol 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations | PSN | 16 | These highlights do not include all the information needed to use AIRDUO ® RESPICLICK ® safely and effectively. See full prescribing information for AIRDUO RESPICLICK. AIRDUO RESPICLICK (fluticasone propionate and salmeterol) inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20240206 |